Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH)

被引:17
作者
Bacher, U [1 ]
Kern, W [1 ]
Schoch, C [1 ]
Hiddemann, W [1 ]
Haferlach, T [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Internal Med 3, Lab Leukemia Diagnost, D-81377 Munich, Germany
关键词
CLL/PL; cytomorphology; interphase fluorescence in situ hybridization; prolymphocytes;
D O I
10.1007/s00277-004-0869-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although interphase fluorescence in situ hybridization (FISH) is routinely used in chronic lymphocytic leukemia (CLL), differences in the chromosomal pattern with respect to morphological subtypes of CLL (typical CLL, CLL/PL, PLL) are still under debate. We studied 153 patients with CLL and correlated cytomorphology on peripheral blood stains with FISH analysis and other prognostic markers. The percentage of prolymphocytes was calculated as a continuous variable and followed published thresholds in parallel while being correlated to FISH analysis. Higher percentages of prolymphocytes were associated significantly with deletion of 17p13. Deletion of 17p13 was most frequently observed in patients with more than 30% prolymphocytes. Trisomy 12 was found mainly in cases with 6-30% prolymphocytes. The percentage of prolymphocytes did not correlate with deletions of 11q23 or with 13q14 abnormalities. In conclusion, we suggest that further research focus on the percentage of prolymphocytes in CLL. Doing so, biologically relevant thresholds for the percentages of prolymphocytes in the peripheral blood and their association to underlying genetic markers could be investigated together with other biologically and especially prognostic markers.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 32 条
[1]   PROPOSALS FOR THE CLASSIFICATION OF CHRONIC (MATURE) B-LYMPHOID AND T-LYMPHOID LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (06) :567-584
[2]  
Bennett John M, 2002, Rev Clin Exp Hematol, V6, P330
[3]   Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study [J].
Bigoni, R ;
Cuneo, A ;
Roberti, MG ;
Bardi, A ;
Rigolin, GM ;
Piva, N ;
Scapoli, G ;
Spanedda, R ;
Negrini, M ;
Bullrich, F ;
Veronese, ML ;
Croce, CM ;
Castoldi, G .
LEUKEMIA, 1997, 11 (11) :1933-1940
[4]   CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells [J].
Buhmann, R ;
Kurzeder, C ;
Rehklau, J ;
Westhaus, D ;
Bursch, S ;
Hiddemann, W ;
Haferlach, T ;
Hallek, M ;
Schoch, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) :968-975
[5]   Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Association with morphology and resistance to conventional chemotherapy [J].
Cano, I ;
Martinez, J ;
Quevedo, E ;
Pinilla, J ;
MartinRecio, A ;
Rodriguez, A ;
Castaneda, A ;
Lopez, R ;
PerezPino, T ;
HernandezNavarro, F .
CANCER GENETICS AND CYTOGENETICS, 1996, 90 (02) :118-124
[6]   The concept of typical and atypical chronic lymphocytic leukaemia [J].
Criel, A ;
Michaux, L ;
De Wolf-Peeters, C .
LEUKEMIA & LYMPHOMA, 1999, 33 (1-2) :33-+
[7]   Further characterization of morphologically defined typical and atypical CLL: A clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases [J].
Criel, A ;
Verhoef, G ;
Vlietinck, R ;
Mecucci, C ;
Billiet, J ;
Michaux, L ;
Meeus, P ;
Louwagie, A ;
VanOrshoven, A ;
VanHoof, A ;
Boogaerts, M ;
VandenBerghe, H ;
DeWolfPeeters, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) :383-391
[8]   Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density [J].
D'Arena, G ;
Dell 'Olio, M ;
Musto, P ;
Cascavilla, N ;
Perla, G ;
Savino, L ;
Greco, MM .
LEUKEMIA & LYMPHOMA, 2001, 42 (04) :649-654
[9]   CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia [J].
D'Arena, G ;
Musto, P ;
Cascavilla, N ;
Dell'Olio, M ;
Di Renzo, N ;
Perla, G ;
Savino, L ;
Carotenuto, M .
LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) :109-114
[10]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916